Search research articles
Contact Us
Filters
Showing results (11-20 of 196) with videos related to
Page
of 20
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
November 20, 2001
New concepts in systemic autoimmunity testing
H P Lehmann, D Block, C Markert-Hahn, et al.
Acta Endocrinologica
|
May 1, 1985
Functional integrity of anterior pituitary cells separated by a density gradient
B Scheikl-Lenz, C Markert, J Sandow, et al.
Der Internist
|
February 4, 2010
[Drug interactions]
V Hafner, B Grün, C Markert, et al.
Cancer Research
|
January 1, 1991
Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells
W Jilg, R Voltz, C Markert-Hahn, et al.
Clinical Pharmacology and Therapeutics
|
September 23, 2011
Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using A limited sampling strategy
S Katzenmaier, C Markert, K-D Riedel, et al.
Physical Review Letters
|
August 25, 2004
Lambda and lambda production in central Pb-Pb collisions at 40, 80, and 158A GeV
T Anticic, B Baatar, D Barna, et al.
Physical Review Letters
|
August 11, 2005
Omega- and Omega+ production in central Pb + Pb collisions at 40 and 158A GeV
C Alt, T Anticic, B Baatar, et al.
Physical Review Letters
|
March 24, 2005
System-size dependence of strangeness production in nucleus-nucleus collisions at squareroot[sNN]=17.3 GeV
C Alt, T Anticic, B Baatar, et al.
Physical Review Letters
|
March 6, 2004
Evidence for an exotic S= -2, Q= -2 baryon resonance in proton-proton collisions at the CERN SPS
C Alt, T Anticic, B Baatar, et al.
Physical Review Letters
|
April 6, 2001
Event-by-event fluctuations of the Kaon-to-Pion ratio in central Pb+Pb collisions at 158 GeV per nucleon
S V Afanasiev, T Anticic, J Bächler, et al.
Page
of 20
Search research articles
Search
Showing results (11-20 of 196) with videos related to
Sort By:
Page
of 20
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
November 20, 2001
New concepts in systemic autoimmunity testing
H P Lehmann, D Block, C Markert-Hahn, et al.
Acta Endocrinologica
|
May 1, 1985
Functional integrity of anterior pituitary cells separated by a density gradient
B Scheikl-Lenz, C Markert, J Sandow, et al.
Der Internist
|
February 4, 2010
[Drug interactions]
V Hafner, B Grün, C Markert, et al.
Cancer Research
|
January 1, 1991
Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells
W Jilg, R Voltz, C Markert-Hahn, et al.
Clinical Pharmacology and Therapeutics
|
September 23, 2011
Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using A limited sampling strategy
S Katzenmaier, C Markert, K-D Riedel, et al.
Physical Review Letters
|
August 25, 2004
Lambda and lambda production in central Pb-Pb collisions at 40, 80, and 158A GeV
T Anticic, B Baatar, D Barna, et al.
Physical Review Letters
|
August 11, 2005
Omega- and Omega+ production in central Pb + Pb collisions at 40 and 158A GeV
C Alt, T Anticic, B Baatar, et al.
Physical Review Letters
|
March 24, 2005
System-size dependence of strangeness production in nucleus-nucleus collisions at squareroot[sNN]=17.3 GeV
C Alt, T Anticic, B Baatar, et al.
Physical Review Letters
|
March 6, 2004
Evidence for an exotic S= -2, Q= -2 baryon resonance in proton-proton collisions at the CERN SPS
C Alt, T Anticic, B Baatar, et al.
Physical Review Letters
|
April 6, 2001
Event-by-event fluctuations of the Kaon-to-Pion ratio in central Pb+Pb collisions at 158 GeV per nucleon
S V Afanasiev, T Anticic, J Bächler, et al.
Page
of 20